Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,834 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
Shimoi T, Nagai SE, Yoshinami T, Takahashi M, Arioka H, Ishihara M, Kikawa Y, Koizumi K, Kondo N, Sagara Y, Takada M, Takano T, Tsurutani J, Naito Y, Nakamura R, Hattori M, Hara F, Hayashi N, Mizuno T, Miyashita M, Yamashita N, Yamanaka T, Saji S, Iwata H, Toyama T. Shimoi T, et al. Among authors: ishihara m. Breast Cancer. 2021 Jul;28(4):985-986. doi: 10.1007/s12282-021-01252-x. Breast Cancer. 2021. PMID: 33886078 Free PMC article. No abstract available.
Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers.
Tono Y, Ishihara M, Miyahara Y, Tamaru S, Oda H, Yamashita Y, Tawara I, Ikeda H, Shiku H, Mizuno T, Katayama N. Tono Y, et al. Among authors: ishihara m. Oncotarget. 2018 Feb 16;9(19):14909-14921. doi: 10.18632/oncotarget.24504. eCollection 2018 Mar 13. Oncotarget. 2018. PMID: 29599915 Free PMC article.
First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer.
Oda H, Ishihara M, Miyahara Y, Nakamura J, Kozuka Y, Iwasa M, Tsunoda A, Yamashita Y, Saito K, Mizuno T, Shiku H, Katayama N. Oda H, et al. Among authors: ishihara m. Case Rep Oncol. 2019 Feb 8;12(1):147-156. doi: 10.1159/000496933. eCollection 2019 Jan-Apr. Case Rep Oncol. 2019. PMID: 31043953 Free PMC article.
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
Shimoi T, Nagai SE, Yoshinami T, Takahashi M, Arioka H, Ishihara M, Kikawa Y, Koizumi K, Kondo N, Sagara Y, Takada M, Takano T, Tsurutani J, Naito Y, Nakamura R, Hattori M, Hara F, Hayashi N, Mizuno T, Miyashita M, Yamashita N, Yamanaka T, Saji S, Iwata H, Toyama T. Shimoi T, et al. Among authors: ishihara m. Breast Cancer. 2020 May;27(3):322-331. doi: 10.1007/s12282-020-01085-0. Epub 2020 Apr 2. Breast Cancer. 2020. PMID: 32240526 Free PMC article.
Risk factors for cisplatin-induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice.
Oda H, Mizuno T, Ikejiri M, Nakamura M, Tsunoda A, Ishihara M, Saito K, Tamaru S, Yamashita Y, Nishimura Y, Nakatani K, Katayama N. Oda H, et al. Among authors: ishihara m. Mol Clin Oncol. 2020 Nov;13(5):58. doi: 10.3892/mco.2020.2127. Epub 2020 Sep 1. Mol Clin Oncol. 2020. PMID: 32953112 Free PMC article.
CD204-positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand-1 expression.
Nagano M, Saito K, Kozuka Y, Ichishi M, Yuasa H, Noro A, Imai N, Shibusawa M, Kimoto M, Ishitobi M, Tono Y, Oda H, Ishihara M, Mizuno T, Ogawa T, Katayama N. Nagano M, et al. Among authors: ishihara m. Oncol Lett. 2021 Jan;21(1):36. doi: 10.3892/ol.2020.12297. Epub 2020 Nov 12. Oncol Lett. 2021. PMID: 33262828 Free PMC article.
Atezolizumab-Induced Sarcoidosis-Like Reaction in a Patient with Metastatic Breast Cancer.
Tsunoda A, Mizuno T, Iida S, Uchida K, Yamashita M, Sukeno K, Oka H, Tono Y, Ishihara M, Saito K, Tamaru S, Yamanaka K, Tawara I. Tsunoda A, et al. Among authors: ishihara m. Case Rep Oncol Med. 2022 Jan 27;2022:2709062. doi: 10.1155/2022/2709062. eCollection 2022. Case Rep Oncol Med. 2022. PMID: 35127188 Free PMC article.
1,834 results